Physician profile
Mark Truman
NPI 1508996075
$1,625.15
in general payments reported to CMS, 2019-2025
9 companies · $58.09 in 2025
The $58.09 reported for 2025 was less than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.00 · 2020: $567 · 2021: $95.82 · 2023: $797 · 2024: $95.88 · 2025: $58.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $403 · Education: $320 · Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $403.48 |
| Education | $319.54 |
| Food and Beverage | $228.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $564.49 | 2019-2025 | Invisalign |
| Ultradent Products INC | $403.48 | 2023 | Opalescence |
| Hu-Friedy Mfg. Co., LLC | $319.54 | 2023 | |
| American Orthodontics Corporation | $253.29 | 2020-2025 | Master Series, Radiance, Empower-Ceramic |
| Lightforce Orthodontics, INC. | $18.69 | 2023 | |
| Envista Holdings Corporation | $18.50 | 2025 | Ortho Solo |
| USA Angelalign Technology Corp | $18.18 | 2024 | |
| Patterson Companies, INC. | $14.50 | 2023 | |
| 3m Company | $14.48 | 2023 | Clarity Aligners |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Truman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.